Back to DEUTSCHE BANK AG\ DEUTSCHE BANK AG\

FDMTFDMT
22 quarters

Position history for DEUTSCHE BANK AG\DEUTSCHE BANK AG\'s holdings in 4D MOLECULAR THERAPEUTICS IN

DEUTSCHE BANK AG\ holds 710,942 shares of FDMT (4D MOLECULAR THERAPEUTICS IN), worth $9.5M as of 2026-Q2. The position was increased (+0.4% shares). FDMT represents 0.0% of DEUTSCHE BANK AG\'s portfolio.

Current Value

$9.5M

Current Shares

710,942

Total Value Change

+$9M

Total Shares Change

+701,231

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
710,942
+0.4%
$9.5M0.0%$13.30
28
2026-Q1
Increased
708,044
+0.5%
$6.6M0.0%$8.46
27
2025-Q4
Increased
704,207
+29.6%
$5.3M0.0%$7.58
34
2025-Q3
Increased
543,331
+139.4%
$4.7M0.0%$8.35
43
2025-Q2
Decreased
226,939
-3.9%
$841,9440.0%$3.84
0
2025-Q1
Decreased
236,157
-2.4%
$762,7870.0%$3.63
0
2024-Q4
Decreased
241,853
-69.9%
$1.3M0.0%$5.30
0
2024-Q3
Increased
802,637
+545.5%
$8.7M0.0%$10.83
44
2024-Q2
Increased
124,339
+2.0%
$2.6M0.0%$20.99
27
2024-Q1
Decreased
121,860
-75.0%
$3.9M0.0%$31.86
0
2023-Q4
Increased
486,993
+3028.0%
$9.9M0.0%$20.26
45
2023-Q3
Decreased
15,569
-97.7%
$198,1930.0%$12.73
0
2023-Q2
Increased
676,153
+742.4%
$12.2M0.0%$17.73
45
2023-Q1
Increased
80,267
+7.1%
$1.4M0.0%$16.75
27
2022-Q4
Increased
74,969
+2.3%
$1.7M0.0%$22.21
26
2022-Q3
Increased
73,320
+451.6%
$589,0000.0%$8.22
39
2022-Q2
Decreased
13,293
-14.3%
$93,0000.0%$7.27
0
2022-Q1
Decreased
15,519
-10.2%
$235,0000.0%$15.49
0
2021-Q4
Increased
17,283
+2.5%
$379,0000.0%$21.87
24
2021-Q3
Increased
16,861
+58.5%
$454,0000.0%$27.92
34
2021-Q2
Increased
10,641
+9.6%
$257,0000.0%$23.50
25
2021-Q1
New
9,711
-
$422,0000.0%$38.55
33

Other major holders of FDMT: VIKING GLOBAL INVESTORS LP, RA CAPITAL MANAGEMENT, L.P., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used